Ivabradine in treatment of symptomatic heart failure and supraventricular tachycardias in patients under six months of age
Ivabradine demonstrated favorable efficacy and safety results in patients under 6 months of age with HF or SVT.
Authors
- Carlos Javier Parramon‐Teixidó (ORCID: https://orcid.org/0000-0001-8023-3979)
- Carlos Ernesto Fernandez‐Garcia (ORCID: https://orcid.org/0000-0003-1182-7348)
- Queralt Ferrer (ORCID: https://orcid.org/0000-0003-3177-4618)
- M. J. Cabañas Poy (ORCID: https://orcid.org/0000-0003-2724-2715)
- Gemma Giralt (ORCID: https://orcid.org/0000-0002-8186-7073)
- Laura Gómez-Ganda (ORCID: https://orcid.org/0000-0003-2441-8607)
Institutions
- Vall d'Hebron Hospital Universitari (ES)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-02-18
- DOI
- https://doi.org/10.3389/fphar.2025.1502375
- Citations
- 4
- Primary Topic
- Heart rate and cardiovascular health
- Type
- article
- Field-Weighted Citation Impact
- 5.55